Hyderabad-based SCIINV Biosciences, UoH partner with UK’s Microbira Ltd
Hyderabad-based SCIINV Biosciences partnered with UK’s Microbira Ltd to develop advanced digital diagnostics targeting antimicrobial resistance. Their joint innovation aims to ensure early pathogen detection, reducing antibiotic misuse and improving healthcare outcomes in India and globally
Hyderabad: SCIINV Biosciences, a Hyderabad-based biotech startup incubated at ASPIRE BioNEST, University of Hyderabad (UoH), announced a partnership with Microbira Ltd, a UK-based biotechnology firm, to develop and deploy next-generation digital diagnostic solutions to strengthen India’s fight against antimicrobial resistance (AMR).
The joint innovation AMRx and MAAP IR is focused on early and precise pathogen identification, thereby minimising the misuse of broad-spectrum antibiotics—a major driver of AMR, particularly in high-disease-burden regions like India.
UoH retired professor Pallu Reddanna underscored the clinical importance of the initiative, stating that the step is a crucial step in curbing inappropriate antibiotic use through timely pathogen detection.
Dr Ranga Reddy Burri, infectious diseases specialist and AMR policy advocate, said combating AMR requires affordable, accessible, and reliable diagnostics.
Emphasising the global relevance of the partnership, Microbira Ltd CEO, Marianne Ismail, said the alliance underscores their shared commitment to tackling one of the most important global health challenges.
